Medline Inc. (MDLN)

Medline Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	580	199	1,556	-
Cash & Cash Equivalents	580	199	1,556	0
Cash Growth	-	-87.21%	-	-
Receivables	3,340	3,219	2,960	-
Inventory	4,662	4,456	3,813	-
Other Current Assets	365	398	480	-
Total Current Assets	8,947	8,272	8,809	-
Property, Plant & Equipment	-	4,595	4,501	-
Goodwill and Intangibles	-	22,624	22,320	-
Other Long-Term Assets	-	487	492	-
Total Long-Term Assets	-	27,706	27,313	-
Total Assets	-	35,978	36,122	-
Accounts Payable	-	869	696	-
Current Debt	-	78	75	-
Other Current Liabilities	2,351	1,493	1,360	-
Total Current Liabilities	2,351	2,440	2,131	-
Long-Term Debt	-	16,416	16,442	-
Other Long-Term Liabilities	-	598	572	-
Total Long-Term Liabilities	-	17,014	17,014	-
Total Liabilities	-	19,454	19,145	-
Total Debt	16,579	16,494	16,517	-
Debt Growth	-	-0.14%	-	-
Comprehensive Income	-	11	188	-
Shareholders' Equity	16,584	16,158	16,744	-
Net Cash (Debt)	-15,999	-16,295	-14,961	0
Working Capital	6,678	5,832	6,678	-

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).